Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
63.5M
-
Shares change
-
+6.16M
-
Total reported value, excl. options
-
$3.06B
-
Value change
-
+$302M
-
Put/Call ratio
-
0.23
-
Number of buys
-
105
-
Number of sells
-
-78
-
Price
-
$48.17
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2019
223 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2019.
NovoCure Ltd - Common Stock (NVCR) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.5M shares
of 112M outstanding shares and own 56.7% of the company stock.
Largest 10 shareholders include FMR LLC (10.4M shares), BAILLIE GIFFORD & CO (8.04M shares), VANGUARD GROUP INC (6.32M shares), Capital World Investors (5.03M shares), BlackRock Inc. (4.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.94M shares), RENAISSANCE TECHNOLOGIES LLC (1.86M shares), Darsana Capital Partners LP (1.75M shares), STATE STREET CORP (1.35M shares), and CREDIT SUISSE AG/ (1.18M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.